Advances in endoluminal therapy for esophageal cancer

Gastrointestinal Endoscopy Clinics of North America

Volumn 23, Issue 1, 2013, Pages 17-39

  Enestvedt, Brintha K ^a   Ginsberg, Gregory G ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Early esophageal cancer; Endoscopic mucosal resection; Endoscopic submucosal dissection; Endoscopic therapy; Mucosal ablation; Palliation of esophageal cancer; Self expanding metal stents; Superficial esophageal cancer

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DISEASE FREE SURVIVAL; ECHOGRAPHY; ENDOLUMENAL THERAPY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; LENGTH OF STAY; LIGATION; LYMPH NODE METASTASIS; MORBIDITY; NONSURGICAL INVASIVE THERAPY; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SELF EXPANDING METAL STENT; SELF EXPANDING STENT; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 84869798098     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.10.003     Document Type: Review

References (87)

1. Luna R.A., Gilbert E., Hunter J.G. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol 2012, 28(4):362-369.
2. Chang A.C., Ji H., Birkmeyer N.J., et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008, 85(2):424-429.
3. Connors R.C., Reuben B.C., Neumayer L.A., et al. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 2007, 205(6):735-740.
4. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347(21):1662-1669.
5. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000. [discussion: 1000-1].
6. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346(15):1128-1137.
7. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349(22):2117-2127.
8. Perry K.A., Enestvedt C.K., Diggs B.S., et al. Perioperative outcomes of laparoscopic transhiatal inversion esophagectomy compare favorably with those of combined thoracoscopic-laparoscopic esophagectomy. Surg Endosc 2009, 23(9):2147-2154.
9. Perry K.A., Enestvedt C.K., Pham T., et al. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg 2009, 144(7):679-684.
10. Swanstrom L.L., Hansen P. Laparoscopic total esophagectomy. Arch Surg 1997, 132(9):943-947. [discussion: 947-9].
11. Jobe B.A., Kim C.Y., Minjarez R.C., et al. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg 2006, 141(9):857-865. [discussion: 865-6].
12. Prasad G.A., Wu T.T., Wigle D.A., et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009, 137(3):815-823.
13. Pech O., Bollschweiler E., Manner H., et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg 2011, 254(1):67-72.
14. Das A., Singh V., Fleischer D.E., et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008, 103(6):1340-1345.
15. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57(9):1200-1206.
16. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005, 446(5):497-504.
17. Ancona E., Rampado S., Cassaro M., et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008, 15(11):3278-3288.
18. Barbour A.P., Jones M., Brown I., et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010, 17(9):2494-2502.
19. Eguchi T., Nakanishi Y., Shimoda T., et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006, 19(3):475-480.
20. Endo M., Yoshino K., Kawano T., et al. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000, 13(2):125-129.
21. Fujita H., Sueyoshi S., Yamana H., et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001, 25(4):424-431.
22. Holscher A.H., Bollschweiler E., Schroder W., et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011, 254(5):802-807. [discussion: 807-8].
23. Leers J.M., DeMeester S.R., Oezcelik A., et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011, 253(2):271-278.
24. Liu L., Hofstetter W.L., Rashid A., et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005, 29(8):1079-1085.
25. Rice T.W., Blackstone E.H., Goldblum J.R., et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001, 122(6):1077-1090.
26. Sepesi B., Watson T.J., Zhou D., et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010, 210(4):418-427.
27. Shimada H., Nabeya Y., Matsubara H., et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 2006, 191(2):250-254.
28. Edge S.B., Byyrd D.R., Compton C.C., et al. American Joint Committee on Cancer Staging manual 2010, Springer, New York, p. 103. 7th edition.
29. van Vliet E.P., Eijkemans M.J., Poley J.W., et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 2006, 63(7):938-947.
30. Bonavina L. Early oesophageal cancer: results of a European multicentre survey. Group Europeen pour l'Etude des Maladies de l'Oesophage. Br J Surg 1995, 82(1):98-101.
31. Noguchi H., Naomoto Y., Kondo H., et al. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg Laparosc Endosc Percutan Tech 2000, 10(6):343-350.
32. Chandawarkar R.Y., Kakegawa T., Fujita H., et al. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol 1996, 61(3):214-217.
33. Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995, 5(3):537-547.
34. Young P.E., Gentry A.B., Acosta R.D., et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 2010, 8(12):1037-1041.
35. Thosani N., Singh H., Kapadia A., et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 2012, 75(2):242-253.
36. Pouw R.E., Heldoorn N., Herrero L.A., et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc 2011, 73(4):662-668.
37. Ishihara R., Tanaka H., Iishi H., et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection. Cancer 2008, 112(10):2166-2172.
38. ASGE Technology Committee, Kantsevoy S.V., Adler D.G., et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc 2008, 68(1):11-18.
39. Chandrasekhara V., Ginsberg G.G. Endoscopic mucosal resection: not your father's polypectomy anymore. Gastroenterology 2011, 141(1):42-49.
40. Alvarez Herrero L., Pouw R.E., van Vilsteren F.G., et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy 2011, 43(3):177-183.
41. Pouw R.E., van Vilsteren F.G., Peters F.P., et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc 2011, 74(1):35-43.
42. Yamamoto H. Endoscopic submucosal dissection of early cancers and large flat adenomas. Clin Gastroenterol Hepatol 2005, 3(7 Suppl 1):S74-S76.
43. Ishihara R., Iishi H., Uedo N., et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008, 68(6):1066-1072.
44. Yamaguchi Y., Katusmi N., Aoki K., et al. Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm. J Clin Gastroenterol 2007, 41(5):472-476.
45. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010, 42(10):781-789.
46. Lyday W.D., Corbett F.S., Kuperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010, 42(4):272-278.
47. Semlitsch T., Jeitler K., Schoefl R., et al. A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus. Surg Endosc 2010, 24(12):2935-2943.
48. Shaheen N.J., Overholt B.F., Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011, 141(2):460-468.
49. Hur C., Choi S.E., Rubenstein J.H., et al. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology 2012, 143(3):567-575.
50. Falk G.W. Radiofrequency ablation of Barrett's esophagus: let's not get ahead of ourselves. Dig Dis Sci 2010, 55(7):1811-1814.
51. Falk G.W. Radiofrequency ablation of Barrett's esophagus: should everybody get it?. Gastroenterology 2009, 136(7):2399-2401. [discussion: 2401-2].
52. Titi M., Overhiser A., Ulusarac O., et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012, 143(3):564-566.e1.
53. Kim H.P., Bulsiewicz W.J., Cotton C.C., et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc 2012, 76(4):733-739.
54. Okoro N.I., Tomizawa Y., Dunagan K.T., et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012, 10(2):150-154.
55. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999, 49(1):8-12.
56. Sharma P., Bhattacharyya A., Garewal H.S., et al. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc 1999, 50(2):159-164.
57. Yang G.R., Zhao L.Q., Li S.S., et al. Endoscopic Nd: YAG laser therapy in patients with early superficial carcinoma of the esophagus and the gastric cardia. Endoscopy 1994, 26(8):681-685.
58. Byrne J.P., Armstrong G.R., Attwood S.E. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998, 93(10):1810-1815.
59. Grade A.J., Shah I.A., Medlin S.M., et al. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 1999, 50(1):18-22.
60. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000, 95(7):1661-1668.
61. Van Laethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 2001, 33(3):257-261.
62. May A., Gossner L., Gunter E., et al. Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience. Endoscopy 1999, 31(6):497-500.
63. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 2005, 62(1):24-30.
64. Wolfsen H.C., Woodward T.A., Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 2002, 77(11):1176-1181.
65. Sibille A., Lambert R., Souquet J.C., et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995, 108(2):337-344.
66. Pacifico R.J., Wang K.K. Role of mucosal ablative therapy in the treatment of the columnar-lined esophagus. Chest Surg Clin N Am 2002, 12(1):185-203.
67. Panjehpour M., Overholt B.F., Haydek J.M., et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 2000, 95(9):2177-2184.
68. Keeley S.B., Pennathur A., Gooding W., et al. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 2007, 14(8):2406-2410.
69. Greenwald B.D., Dumot J.A., Abrams J.A., et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc 2010, 71(4):686-693.
70. Halsey K.D., Chang J.W., Waldt A., et al. Recurrent disease following endoscopic ablation of Barrett's high-grade dysplasia with spray cryotherapy. Endoscopy 2011, 43(10):844-848.
71. Guarner-Argente C., Buoncristiano T., Furth E.E., et al. Long term outcomes of patients with Barrett's esophagus and high grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointest Endosc 2012, in press.
72. McCaughan J.S., Ellison E.C., Guy J.T., et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg 1996, 62(4):1005-1009. [discussion: 1009-10].
73. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995, 42(6):507-512.
74. Rupinski M., Zagorowicz E., Regula J., et al. Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II). Am J Gastroenterol 2011, 106(9):1612-1620.
75. Eickhoff A., Jakobs R., Schilling D., et al. Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC. Endoscopy 2007, 39(7):637-642.
76. Cash B.D., Johnston L.R., Johnston M.H. Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol 2007, 5:34.
77. Costamagna G., Shah S.K., Tringali A., et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc 2003, 17(6):891-895.
78. Conio M., Repici A., Battaglia G., et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007, 102(12):2667-2677.
79. Verschuur E.M., Repici A., Kuipers E.J., et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008, 103(2):304-312.
80. Sharma P., Kozarek R. Practice parameters committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010, 105(2):258-273. [quiz: 274].
81. Siersema P.D., Hop W.C., van Blankenstein M., et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001, 54(2):145-153.
82. Jacobson B.C., Hirota W., Baron T.H., et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003, 57(7):817-822.
83. Chen J., Chen Z.M., Pang L.W., et al. Deployment of self-expanding metallic stents under fluoroscopic guidance in patients with malignant esophagorespiratory fistula. Hepatogastroenterology 2011, 58(105):64-68.
84. Dobrucali A., Caglar E. Palliation of malignant esophageal obstruction and fistulas with self expandable metallic stents. World J Gastroenterol 2010, 16(45):5739-5745.
85. Talreja J.P., Eloubeidi M.A., Sauer B.G., et al. Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis. Surg Endosc 2012, 26(6):1664-1669.
86. ASGE Technology Committee, Varadarajulu S., Banerjee S., et al. Enteral stents. Gastrointest Endosc 2011, 74(3):455-464.
87. Sreedharan A., Harris K., Crellin A., et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2009, (4). CD005048.